UPDATE 1-GSK appeal against fine over 'pay-for-delay' drug deals faces EU rebuke
(adds details, background)BRUSSELS, Jan 22 (Reuters) - British drugmaker GlaxoSmithKline may have harmed competition with payments it made to generic drugmakers to delay the launch of cheap copies of an antidepressant, according to an adviser to ...
Read more